Sign inJoin free

Watch / Small Cap

Control Bionics stepping towards global reach

16 Dec 20244:41

Control Bionics stepping towards global reach

General information only. ausbiz videos are general information only, produced by Ausbiz TV Pty Ltd, a media business that doesn’t give financial advice. They don’t take into account your objectives, financial situation or needs. Consider whether it’s right for you and read the PDS and TMD before acting on anything you watch.

About this video

Jeremy Steele from Control Bionics (ASX:CBL) shares that the company secures agreements in two major markets. The company invests in NeuroBounce, aiming to enhance jump training for athletes using their EMG technology. The goal is to bring this program to Australia.

Jeremy mentions a memorandum with Stroke Lab in Tokyo. This collaboration involves using Control Bionics' technology to improve rehabilitation for stroke and other neurological conditions. The plan is to introduce the NeuroStrip technology to Japan and eventually Australia.

Control Bionics (ASX:CBL) gains a 20% stake in NeuroBounce, introducing a subscription-based model. This includes upfront costs for equipment and recurring revenue through software and athlete fees. Jeremy highlights this shift towards more sustainable revenue streams.

More like this

We value your privacy

We use essential cookies to make the site work. Non-essential cookies help us improve the experience. You can accept or reject non-essential cookies. Privacy policy